Skip to content

AN ACT relating to Ibogaine research in the Commonwealth.

This bill did not become law and its session has ended, so it can no longer move. It would have to be reintroduced.

KY SB 240 · Senate Bill · 2025RS

Stage
Session ended
Started in
Senate
Latest action
Feb 20, 2025

What it does

Create new sections of KRS 218A to define terms; establish the intent of the General Assembly that ibogaine is worthy of clinical research, trials, and studies as a potential viable therapeutic treatment of opioid dependence and any other co-occurring mental health disorders; establish a trust and agency account entitled the ibogaine research fund; establish a process for private entities to apply to the Department of Agriculture for access to funds in the Ibogaine Research Fund.

Read the full text

Where it stands

This bill did not become law and its session has ended, so it can no longer move. It would have to be reintroduced.

  1. Introduced (Current step)

    Introduced · Feb 20, 2025

  2. Committee (Needs attention)

    The session ended first

  3. Floor (Not started)

  4. Law (Not started)

What moved

Loading recorded actions…

In the news

Reporting that may mention this subject. Possible matches are labeled.

Loading coverage…

Work with this bill

AN ACT relating to Ibogaine research in the Commonwealth. | 52